Digital health is unlocking new avenues for innovation across life sciences, and industry leaders are keen to tap into the potential of this burgeoning area.
In the year since the UK went into its first lockdown to limit the spread of COVID-19 the country’s health service has undergone an unprecedented digital transformation.
The ubiquity of digital technology allows pharma reps to communicate with healthcare professionals (HCPs) through their preferred channels, making a positive difference to engagement, relat
Pharma is playing catch-up with digital technology – but in this age of big data and AI, there are benefits to adopting it to help engage with clients.
The industry has experienced a sustained period of change since its blockbuster heyday in the 1990s and continues to evolve, with significant ramifications for new pharmaceutical launches.<
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS